Skip to content

Clinical trials

Parkinson Disease trials with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Not applicable Clear all

1,976 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20025
20032
20047
20058
200610
200716
200813
200922
201027
201128
201237
201360
201480
201594
201695
201791
2018106
2019143
2020125
2021178
2022150
2023163
2024175
2025168
2026164

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed918
Unknown status377
Recruiting319
Not yet recruiting113
Terminated92
Active, not recruiting72
Enrolling by invitation42
Withdrawn38
Suspended5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Florida25
VA Office of Research and Development25
National Taiwan University Hospital21
Oregon Health and Science University17
University Hospital, Clermont-Ferrand17
University of Alabama at Birmingham17
University of Colorado, Denver17
Ruijin Hospital16
University Hospital, Toulouse16
InSightec15

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease1,976
Cognitive Dysfunction67
Movement Disorders58
Gait Disorders, Neurologic51
Parkinsonian Disorders51
Stroke47
Multiple Sclerosis45
Essential Tremor43
Alzheimer Disease39
Neurodegenerative Diseases38

Trials

Showing 26 to 50 of 1,976. Each trial links to its page on Pharma Observatory.

1,876 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.